Characteristics | Survivors (n = 159) | Non-survivors (n = 67) | p value |
---|---|---|---|
Age, years | 4.0 (0.6, 12.7) | 4.6 (0.8, 14.4) | 0.273 |
Male, n (%) | 83 (52.2) | 33(49.3) | 0.771 |
Coexisting conditions, n (%) | |||
 Cardiac disease | 44 (27.7) | 12 (17.9) | 0.132 |
 Hemato-oncologic disease | 32 (20.1) | 19 (28.4) | 0.222 |
 Neurologic disease | 25 (15.7) | 7 (10.4) | 0.404 |
 Pulmonary disease | 20 (12.6) | 13 (19.4) | 0.216 |
 Chronic renal disease | 20 (12.6) | 7 (10.4) | 0.667 |
 Gastrointestinal disease | 12 (7.5) | 6 (9.0) | 0.789 |
 Endocrinologic disease | 6 (3.8) | 3 (4.5) | 0.805 |
 PRISM III score | 11.0 (7.0, 15.0) | 17.0 (10.0, 21.5) | < 0.001 |
 Duration of PICU stay (days) | 12.0 (7.0, 35.0) | 11.5 (4.0, 18.0) | 0.062 |
 Mechanical ventilation, n (%) | 82 (51.6) | 62 (92.5) | < 0.001 |
 VIS | 12.0 (7.0, 25.0) | 22.5 (8.0, 55.0) | 0.009 |
 Lactic acid at admission, (mmol/l) | 1.3 (0.9, 2.4) | 3.9 (1.6, 8.0) | < 0.001 |
 Brain natriuretic peptide (pg/mL) | 286.0 (62.5, 1015.0) | 461.0 (74.0, 1624.5) | 0.271 |
 Proven microorganisms, n (%) | 91 (57.2) | 45 (67.2) | 0.183 |
Gram-positive | 52 (32.7) | 26 (38.8) | 0.444 |
 Staphylococci | 24 (15.1) | 14 (20.9) | 0.331 |
 Streptococci | 10 (6.3) | 4 (6.0) | 0.928 |
 Enterococcus | 15 (9.4) | 7 (10.4) | 0.814 |
 Other | 3 (1.9) | 1 (1.5) | 0.837 |
Gram-negative | 34 (21.4) | 13 (19.4) | 0.858 |
 Klebsiella | 15 (9.4) | 2 (3.0) | 0.106 |
 Pseudomonas | 5 (3.1) | 3 (4.5) | 0.697 |
 E.coli | 5 (3.1) | 4 (6.0) | 0.456 |
 Acinetobacter | 6 (3.8) | 4 (6.0) | 0.488 |
 Other | 3 (1.9) | 0 (0) | 0.557 |
Fungi | 5 (3.1) | 6 (9.0) | 0.088 |
 Candida | 5 (3.1) | 6 (9.0) | 0.088 |
 CVP at 6 h, mmHg | 8.0 (5.0, 11.0) | 10.0 (7.0, 16.0) | < 0.001 |
Fluid overload, % | |||
 0–24 h | 0.7 (−0.6, 2.6) | 1.3 (−0.2, 3.6) | 0.100 |
 0–48 h | 1.9 (−0.5, 5.7) | 3.9 (0.9, 9.3) | 0.006 |
 0–72 h | 3.8 (0.3, 7.9) | 5.1 (1.8, 10.9) | 0.055 |